The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice.
- 2022-10-05
- Clinical Trial
- Food & Function 13(19)
- Junyu Hao
- Yongli Zhang
- Tao Wu
- R. Liu
- Wenjie Sui
- Jiangu Zhu
- S. Fang
- Jieting Geng
- M. Zhang
- PubMed: 36056711
- DOI: 10.1039/d2fo01109c
- Low evidence
- Animal Study
BL21 enhanced the anti-oxidative capacity, increased the hepatic glycogen content, and significantly decreased the gene expression levels of glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK) in the livers of diabetic mice.
- Effect
- Beneficial
- Effect size
- Large